anurajms/meta_analysis huggingface dataset:
outcomes:
Planned early delivery versus expectant management for monoamniotic twins
1. Morbidity Index 2. Perinatal Death
outcomes:
Fetal and umbilical Doppler ultrasound in normal pregnancy
1. Cesarean Section 2. Stillbirth 3. Neonatal Death 4. Intensive Care 5. Preterm Infant
outcomes:
External cephalic version for breech presentation at term
1. Cesarean Section 2. Apgar Score 3. Delivery Of Cephalic Presentation 4. Perinatal Death
outcomes:
Bed rest in singleton pregnancies for preventing preterm birth
1. Premature Delivery 2. Perinatal Death 3. Low Birth Weight Infant 4. Intensive Care
outcomes:
Oral analgesia for relieving post‐caesarean pain
1. Pain Relief
outcomes:
Community‐based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes
1. Neonatal Death 2. Maternal Death
outcomes:
Combined hormonal versus nonhormonal versus progestin‐only contraception in lactation
1. Breast Milk Finding 2. Pregnancy 3. Height and growth measurements 4. Able To Perform Breast-feeding 5. Finding Of Quantity Of Lactation
outcomes:
Interventions for helping to turn term breech babies to head first presentation when using external cephalic version
1. Cesarean Section 2. Fetal Bradycardia 3. Breech Malpresentation Successfully Converted To Cephalic Presentation 4. Breech Presentation
outcomes:
Group versus conventional antenatal care for women
1. Breastfeeding Started 2. Small For Gestational Age 3. Fetal Gestation At Delivery 4. Perinatal Death 5. Low Birth Weight Infant 6. Vaginal Delivery 7. Intensive Care 8. Patient Satisfaction
outcomes:
Antibiotic regimens for postpartum endometritis
1. Maternal Death
outcomes:
Controlled cord traction for the third stage of labour
1. Removal Retained Placenta 2. Maternal Blood Loss Heavy
outcomes:
Prophylactic manual rotation for fetal malposition to reduce operative delivery
1. Cesarean Section 2. Forceps Delivery 3. Stillbirth 4. Neonatal Death 5. Maternal Death 6. Ventouse Extraction
outcomes:
Routine perineal shaving on admission in labour
1. Neonatal Infection 2. Postpartum Fever 3. Wound Infection
outcomes:
Interventions for preventing or reducing domestic violence against pregnant women
1. Intimate Partner Violence 2. Low Birth Weight Infant
outcomes:
Antibiotics for prelabour rupture of membranes at or near term
1. Infection 2. Anaphylaxis 3. Stillbirth 4. Cardiac Arrest 5. Respiratory Arrest 6. Neonatal Death 7. Intensive Care 8. Maternal Death During Childbirth
outcomes:
Early versus late initiation of epidural analgesia for labour
1. Cesarean Section 2. Forceps Delivery 3. Finding Of Duration Of Labor 4. Ventouse Extraction
outcomes:
High‐dose versus low‐dose oxytocin infusion regimens for induction of labour at term
1. Cesarean Section 2. Maternal morbidity 3. Epidural Analgesia 4. Hypertonic Uterine Dysfunction 5. Neonatal morbidity 6. Neonatal Death 7. Vaginal Delivery 8. Uterine Rupture 9. Maternal Death 10. Cervix
outcomes:
Antibiotic prophylaxis for third‐ and fourth‐degree perineal tear during vaginal birth
1. Infection - Perineal Wound 2. Pain 3. Fever
outcomes:
Fetal pulse oximetry for fetal assessment in labour
1. Cesarean Section 2. Cerebral Hypoxia-Ischemia 3. Neonatal Seizure
outcomes:
Fetal assessment methods for improving neonatal and maternal outcomes in preterm prelabour rupture of membranes
1. Fetal death 2. Neonatal Death 3. Maternal Death
outcomes:
Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy
1. Infection 2. Cesarean Section 3. Premature Delivery 4. Stillbirth 5. Neonatal Death 6. Low Birth Weight Infant 7. Adverse Event
outcomes:
Magnesium sulphate for preventing preterm birth in threatened preterm labour
1. Chronic Lung Disease 2. Intellect Impaired 3. Periventricular Leukomalacia 4. Developmental Delay 5. Respiratory Arrest 6. Neonatal Death 7. Birth Outcome 8. Maternal Death 9. Visual Disability 10. Extremely Preterm Infant (<28 weeks) 11. Sensorineural Hearing Loss 12. Cardiac Arrest 13. Intraventricular Hemorrhage Neonatal 14. Cerebral Palsy 15. Intensive Care
outcomes:
Surgical techniques for uterine incision and uterine closure at the time of caesarean section
1. Postoperative Fever
outcomes:
Combination of tocolytic agents for inhibiting preterm labour
1. Infant Death 2. Chronic Lung Disease 3. Intraventricular Hemorrhage 4. Admission to Intensive Care Unit 5. Respiratory Arrest 6. Periventricular Leukomalacia 7. Premature Labor 8. Neonatal Death 9. Maternal Death 10. Sensory Disability 11. Fetal Death 12. Cardiac Arrest 13. Regular Uterine Contractions
outcomes:
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia
1. Premature Delivery 2. Live Birth
outcomes:
Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term
1. Cesarean Section 2. Maternal morbidity 3. Epidural Analgesia 4. Hypertonic Uterine Dysfunction 5. Oxytocin Increased 6. Neonatal morbidity 7. Perinatal Death 8. Vaginal Delivery 9. Uterine Rupture 10. Maternal Death
outcomes:
Oral misoprostol for induction of labour
1. Cesarean Section 2. Maternal morbidity 3. Hypertonic Uterine Dysfunction 4. Neonatal morbidity 5. Perinatal Death 6. Vaginal Delivery 7. Maternal Death
outcomes:
Extra fluids for breastfeeding mothers for increasing milk production
1. Breast Milk Finding 2. Breast Fed 3. Weight Gain
outcomes:
Oxytocin receptor antagonists for inhibiting preterm labour
1. Infant Death 2. Extremely Preterm Infant (<28 weeks) 3. Lung disorder 4. Cardiac Arrest 5. Respiratory Arrest 6. Perinatal Death 7. Maternal Death 8. Birth 9. Intensive Care
outcomes:
Calcium channel blockers for inhibiting preterm labour and birth
1. Neonatal Death 2. Maternal Death
outcomes:
Prostaglandins for management of retained placenta
1. Removal Retained Placenta 2. Blood Transfusion 3. Postpartum Hemorrhage 4. Maternal Death
outcomes:
Nitric oxide donors for treating preterm labour
1. Chronic Lung Disease 2. Intraventricular Hemorrhage 3. Cardiac Arrest 4. Respiratory Arrest 5. Neonatal Respiratory Distress Syndrome 6. Maternal Death 7. Mechanical ventilation
outcomes:
Planned home versus hospital care for preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks' gestation
1. Maternal morbidity 2. Neonatal Infection 3. Perinatal Death 4. Maternal Death 5. Sepsis Of The Newborn
outcomes:
Indwelling bladder catheterisation as part of intraoperative and postoperative care for caesarean section
1. Urinary Tract Infection 2. Intraoperative Injury
outcomes:
Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes
1. Birth Weight 2. Hearing Finding 3. Low Blood Pressure 4. Inflammatory Disease Of Liver 5. Adverse Event 6. Disability 7. Pulmonary Edema 8. Premature Delivery 9. Hyperglycemia 10. Dyspnea 11. Hypokalemia 12. Complication 13. Cardiac Complication 14. Neonatal Respiratory Distress Syndrome 15. Perinatal Death 16. Neonatal Death 17. Maternal Death 18. Gestational Age 19. Eyes and vision 20. Myocardial Infarction 21. Cardiac Arrhythmia 22. Chest Pain 23. Cardiac Arrest 24. Neurological Finding 25. Cerebral Palsy 26. Perinatal Periventricular Hemorrhage 27. Mechanical ventilation 28. Palpitations 29. Intelligence
outcomes:
Tocolytics for preterm premature rupture of membranes
1. Fetal Death 2. Neonatal Death
outcomes:
Treatment for primary postpartum haemorrhage
1. Morbidity Index 2. Hysterectomy 3. Maternal Death 4. Intensive Care
outcomes:
Elective birth at 37 weeks’ gestation for women with an uncomplicated twin pregnancy
1. Cesarean Section 2. Maternal morbidity 3. Perinatal Death 4. Maternal Death 5. Perinatal morbidity
outcomes:
Interventions at caesarean section for reducing the risk of aspiration pneumonitis
1. Aspiration Pneumonitis 2. Hyperchlorhydria 3. Abnormal Gastric Acidity
outcomes:
Hyaluronidase for reducing perineal trauma
1. Episiotomy 2. Perineal Pain 3. Perineal Laceration
outcomes:
Betamimetics for inhibiting preterm labour
1. Chronic Lung Disease 2. Bronchopulmonary Dysplasia Of Newborn 3. Length Of Stay 4. Perinatal Death 5. Birth 6. Neurodevelopmental Delay 7. Respiratory Distress
outcomes:
Progestational agents for treating threatened or established preterm labour
1. Premature Delivery 2. Low Birth Weight Infant
outcomes:
Interventions for the treatment of twin‐twin transfusion syndrome
1. Stillbirth 2. Neurodevelopmental Delay
outcomes:
Amnioinfusion for meconium‐stained liquor in labour
1. Maternal morbidity 2. Perinatal Death 3. Maternal Death 4. Perinatal morbidity 5. Meconium Aspiration Syndrome
outcomes:
Planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean birth
1. Maternal morbidity 2. Neonatal morbidity 3. Neonatal Death 4. Maternal Death
outcomes:
Methods of repair for obstetric anal sphincter injury
1. Faecal incontinence 2. Dyspareunia 3. Urgent Desire For Stool 4. Perineal Pain 5. Quality of Life 6. Unable To Control Flatus
outcomes:
Fetal manipulation for facilitating tests of fetal wellbeing
1. Cardiotocography Abnormal 2. Cardiotochogram Finding
outcomes:
Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing
1. Cardiotocography 2. Fetal Movements
outcomes:
Prophylactic antibiotics for inhibiting preterm labour with intact membranes
1. Infant Death 2. Fetal Death 3. Cardiac Arrest 4. Respiratory Arrest 5. Neonatal Death 6. Maternal Death 7. Adverse Event 8. Nervous system disorder
outcomes:
Antibiotics for preterm rupture of membranes
1. Maternal morbidity 2. Neonatal morbidity 3. Perinatal Death 4. Maternal Death
outcomes:
Postnatal parental education for optimizing infant general health and parent‐infant relationships
1. Age and growth 2. Finding Related To Sleep 3. Preventative intervention 4. Crying Infant
outcomes:
Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period
1. Maternal morbidity 2. Haemorrhage 3. Maternal Death
outcomes:
Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour
1. Premature Delivery 2. Stillbirth 3. Neonatal Death 4. Birth 5. Maternal Death 6. Neurodevelopmental Disorder
outcomes:
Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour
1. Disability 2. Infant Death 3. Premature Delivery 4. Perinatal Death 5. Neonatal Death
outcomes:
Combined oestrogen and progesterone for preventing miscarriage
1. Premature Delivery 2. Perinatal Death 3. Miscarriage
outcomes:
Titrated oral misoprostol for augmenting labour to improve maternal and neonatal outcomes
1. Maternal morbidity 2. Hypertonic Uterine Dysfunction 3. Stillbirth 4. Neonatal Death 5. Maternal Death
outcomes:
Package of care for active management in labour for reducing caesarean section rates in low‐risk women
1. Cesarean Section
outcomes:
Caesarean section versus vaginal delivery for preterm birth in singletons
1. Birth Asphyxia 2. Intensive Care
outcomes:
Restricting oral fluid and food intake during labour
1. Cesarean Section 2. Apgar Score 3. Vaginal Delivery 4. Hypoglycemia 5. Patient Satisfaction
outcomes:
Relaxin for preventing preterm birth
1. Serious Adverse Event 2. Finding Of Speed Of Delivery 3. Death
outcomes:
Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care
1. Cesarean Section
outcomes:
Internal versus external tocodynamometry during induced or augmented labour
1. Hypertonic Uterine Dysfunction 2. Apgar Score 3. Arterial Blood pH 4. Uterine Rupture 5. Intensive Care
outcomes:
Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks
1. Choriocarcinoma 2. Fetal Trauma 3. Premature Delivery 4. Umbilical Cord Prolapse 5. Sepsis 6. Premature Labor 7. Perinatal Death 8. Neonatal Death 9. Maternal Death 10. Placental Abruption
outcomes:
Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth
1. Handicapped Child 2. Premature Delivery 3. Perinatal Death
outcomes:
Interventions for supporting pregnant women's decision‐making about mode of birth after a caesarean
1. Adverse Event
outcomes:
Castor oil, bath and/or enema for cervical priming and induction of labour
1. Cesarean Section 2. Epidural Analgesia 3. Hypertonic Uterine Dysfunction 4. Oxytocin Increased 5. Vaginal Delivery 6. Uterine Rupture
outcomes:
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
1. Perinatal Death 2. Maternal Death
outcomes:
Diet or exercise, or both, for weight reduction in women after childbirth
1. Weight change 2. Weight Loss 3. Body weight
outcomes:
Enemas during labour
1. Neonatal Infection 2. Perineal Infection 3. Endometritis 4. Perineal Wound Dehiscence
outcomes:
Telephone support for women during pregnancy and the first six weeks postpartum
1. Anxiety
outcomes:
Postpartum misoprostol for preventing maternal mortality and morbidity
1. Maternal Death
outcomes:
High‐dose versus low‐dose oxytocin for augmentation of delayed labour
1. Cesarean Section 2. Finding Of Duration Of Labor 3. Perinatal Death 4. Neonatal Death 5. Patient Satisfaction
outcomes:
Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes
1. Maternal morbidity 2. Postpartum Hemorrhage 3. Neonatal Death 4. Maternal Death
outcomes:
Oxytocin augmentation of labour in women with epidural analgesia for reducing operative deliveries
1. Cesarean Section 2. Forceps Delivery 3. Deliveries By Vacuum Extractor
outcomes:
Oxytocin versus no treatment or delayed treatment for slow progress in the first stage of spontaneous labour
1. Cesarean Section 2. Maternal morbidity 3. Hypertonic Uterine Dysfunction 4. Neonatal morbidity 5. Neonatal Death 6. Maternal Death
outcomes:
Support for mothers, fathers and families after perinatal death
1. Normal Grief Reaction 2. Grief Reaction 3. Evaluation Of Satisfaction With Healthcare
outcomes:
Intravenous fluids for reducing the duration of labour in low risk nulliparous women
1. Weight Loss Neonatal 2. Cesarean Section 3. Apgar Score 4. Hypervolemia 5. Intensive Care 6. Assisted Delivery
outcomes:
Amniotomy for shortening spontaneous labour
1. Cesarean Section 2. Maternal morbidity 3. Pain 4. Oxytocin 5. Apgar Score Low 6. Admission to Intensive Care Unit 7. Neonatal morbidity 8. Length Of Stay 9. Perinatal Death 10. Maternal Death 11. Patient Satisfaction
outcomes:
Antispasmodics for labour
1. Finding Of Duration Of Labor 2. Cervical Dilatation Finding 3. Delivery 4. Pain Relief
outcomes:
Umbilical cord antiseptics for preventing sepsis and death among newborns
1. Omphalitis 2. Neonatal Death 3. Tetanus Neonatorum 4. Umbilical Sepsis
outcomes:
Cervical pessary for preventing preterm birth
1. Premature Delivery
outcomes:
Antenatal immunoglobulin for fetal red blood cell alloimmunization
1. Intensive Care 2. Hemoglobin concentration
outcomes:
Maternal position during caesarean section for preventing maternal and neonatal complications
1. Maternal Hypotension Syndrome 2. Air Embolism 3. Maternal Hypertension
outcomes:
Anti‐D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation
1. Kleihauer-betke Test Positive 2. Alloimmunisation 3. Indirect Coombs Test Positive
outcomes:
Methods for administering subcutaneous heparin during pregnancy
1. Venous Thrombosis
outcomes:
Interventions for supporting parents’ decisions about autopsy after stillbirth
1. Decisional Conflict 2. Investigations
outcomes:
Antibiotics for mastitis in breastfeeding women
1. Adverse Drug Reaction 2. Breast Fed 3. Hospitalization
outcomes:
Magnesium sulphate for women at term for neuroprotection of the fetus
1. Infant Death 2. Fetal Death 3. Respiratory Arrest 4. Cardiac Arrest 5. Neonatal Death 6. Cerebral Palsy 7. Maternal Death
outcomes:
Morning versus evening induction of labour for improving outcomes
1. Fetal Death 2. Neonatal Death
outcomes:
Abdominal decompression in normal pregnancy
1. Finding Of Fetal Growth 2. Perinatal Death 3. Pre-eclampsia 4. Perinatal morbidity
outcomes:
Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and health equity in the adult population
1. Body Mass Index 2. Self Efficacy 3. General well-being 4. Depression 5. Physical Exercises 6. Lung function test 7. Maintaining Confidentiality Of Patient Information 8. Stress 9. Alcohol Use 10. All Cause Mortality 11. Psychological Finding 12. Tobacco Use 13. Quality of Life 14. Physical Health Problems 15. Breast Fed 16. Sexualized Behavior 17. Illicit Drug Use 18. Psychological Adaptation
outcomes:
Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations
1. Quality of Life 2. Health-related Behavior Finding 3. Death 4. Health Status
outcomes:
Interventions to improve water quality and supply, sanitation and hygiene practices, and their effects on the nutritional status of children
1. Birth Weight 2. Body weight 3. Measurement Of Skin Fold Thickness 4. Wasting 5. Assessment Using Bmi (body Mass Index) 6. Height 7. Nutritional status 8. Mid-upper arm circumference 9. Nutritional Stunting
outcomes:
Antibiotics prior to or at the time of embryo transfer in ART
1. Pregnancy 2. Adverse Event
outcomes:
In vitro fertilisation for unexplained subfertility
1. Multiple Pregnancy 2. Live Birth 3. Clinical Pregnancy 4. Ovarian Hyperstimulation Syndrome
outcomes:
Timed intercourse for couples trying to conceive
1. Live Birth 2. Pregnancy 3. Clinical Pregnancy 4. Assessment Using Perceived Stress Scale
outcomes:
Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility
1. Premature Delivery 2. Live Birth 3. Multiple Pregnancy 4. Stillbirth 5. Pre-eclampsia 6. Adverse Event
outcomes:
Non‐surgical therapies for Peyronie's disease
1. Quality of Life 2. Able To Have Sexual Intercourse 3. Adverse Event
outcomes:
Progestin intrauterine devices versus copper intrauterine devices for emergency contraception
1. Device Insertion Failed 2. Pregnancy
outcomes:
Follicular flushing during oocyte retrieval in assisted reproductive techniques
1. Number of Oocytes Aspirated 2. Duration Of Surgery 3. Livebirth 4. Miscarriage 5. Clinical Pregnancy 6. Number of Embryos
outcomes:
Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
1. Pain 2. Live Birth 3. Clinical Pregnancy
outcomes:
Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse
1. Live Birth 2. Pregnancy 3. Clinical Pregnancy 4. Miscarriage
outcomes:
Cleavage‐stage versus blastocyst‐stage embryo transfer in assisted reproductive technology
1. Frozen Embryo Transfer 2. IVF cycle failure 3. Live Birth 4. Multiple Pregnancy 5. Clinical Pregnancy 6. Miscarriage
outcomes:
Growth hormone for in vitro fertilisation (IVF)
1. Pregnant 2. Edema 3. Congenital abnormality 4. Embryo Transfer 5. Multiple Pregnancy 6. Live Birth 7. Oocyte retrieval 8. Ectopic Pregnancy 9. Ovarian Hyperstimulation Syndrome
outcomes:
Oxytocin antagonists for assisted reproduction
1. Live Birth 2. Complication 3. Miscarriage 4. Clinical Pregnancy
outcomes:
Surgical or radiological treatment for varicoceles in subfertile men
1. Live Birth 2. Pregnancy 3. Quality of Life 4. Complication 5. Symptom recurrence
outcomes:
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
1. Number of Oocytes Aspirated 2. IVF cycle failure 3. Live Birth 4. Clinical Pregnancy 5. Ovarian Hyperstimulation Syndrome
outcomes:
Selective serotonin re‐uptake inhibitors for premature ejaculation in adult men
1. Withdrawal Due To Adverse Events 2. Patient Satisfaction 3. Patient-Reported Outcome
outcomes:
Fresh versus frozen embryo transfers in assisted reproduction
1. Binary Individualized Outcome Measure 2. Live Birth 3. Multiple Pregnancy 4. Time To Pregnancy 5. Pregnancy 6. Complication Of Pregnancy 7. Miscarriage 8. Ovarian Hyperstimulation Syndrome
outcomes:
Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
1. Endometrial Thickness 2. IVF cycle failure 3. Multiple Pregnancy 4. Live Birth 5. Clinical Pregnancy 6. Miscarriage
outcomes:
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
1. Ongoing Pregnancy 2. Live Birth 3. Miscarriage 4. Clinical Pregnancy
outcomes:
Hyaluronic acid in embryo transfer media for assisted reproductive technologies
1. Multiple Pregnancy 2. Live Birth 3. Clinical Pregnancy 4. Adverse Event
outcomes:
Number of embryos for transfer following in vitro fertilisation or intra‐cytoplasmic sperm injection
1. Multiple Pregnancy 2. Live Birth 3. Clinical Pregnancy 4. Miscarriage
outcomes:
Fluid and pharmacological agents for adhesion prevention after gynaecological surgery
1. Live Birth 2. Pelvic Pain 3. Clinical Pregnancy 4. Adverse Event 5. Adhesion
outcomes:
Barrier agents for adhesion prevention after gynaecological surgery
1. Pelvic Adhesions 2. Live Birth 3. Pelvic Pain
outcomes:
Intra‐uterine insemination for unexplained subfertility
1. Live Birth 2. Multiple Pregnancy 3. Ectopic Pregnancy 4. Clinical Pregnancy 5. Miscarriage 6. Ovarian Hyperstimulation Syndrome
outcomes:
Regular (ICSI) versus ultra‐high magnification (IMSI) sperm selection for assisted reproduction
1. Congenital abnormality 2. Live Birth 3. Miscarriage 4. Clinical Pregnancy
outcomes:
Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
1. Multiple Pregnancy 2. Live Birth 3. Miscarriage 4. Clinical Pregnancy 5. Ovarian Hyperstimulation Syndrome
outcomes:
Surgical treatment of fibroids for subfertility
1. Ongoing Pregnancy 2. Live Birth 3. Preterm Spontaneous Labor With Preterm Delivery 4. Miscarriage 5. Clinical Pregnancy 6. Deliveries By Cesarean
outcomes:
Granulocyte‐colony stimulating factor administration for subfertile women undergoing assisted reproduction
1. Small For Gestational Age 2. Congenital abnormality 3. Multiple Pregnancy 4. Live Birth 5. Adverse Reaction 6. Ectopic Pregnancy 7. Adherent Placenta 8. Miscarriage 9. Clinical Pregnancy
outcomes:
Semen preparation techniques for intrauterine insemination
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Clinical Pregnancy 5. Miscarriage
outcomes:
Temperature of embryo culture for assisted reproduction
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Miscarriage 5. Clinical Pregnancy
outcomes:
Interventions for unexplained infertility: a systematic review and network meta‐analysis
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Ovarian Hyperstimulation Syndrome
outcomes:
Time‐lapse systems for embryo incubation and assessment in assisted reproduction
1. Live Birth 2. Stillbirth 3. Miscarriage 4. Clinical Pregnancy
outcomes:
Strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception
1. Pregnancy 2. Contraception 3. Adverse Event
outcomes:
Interventions using social networking sites to promote contraception in women of reproductive age
1. Contraception
outcomes:
Interventions for emergency contraception
1. Irregular Menstruation 2. Adverse Drug Reaction 3. Pregnancy
outcomes:
Inositol for subfertile women with polycystic ovary syndrome
1. Ovulation Present 2. Multiple Pregnancy 3. Live Birth 4. Clinical Pregnancy 5. Miscarriage
outcomes:
Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
1. Live Birth 2. Complication 3. Clinical Pregnancy 4. Miscarriage
outcomes:
Penile rehabilitation for postprostatectomy erectile dysfunction
1. Treatment Withdrawal 2. Penis Finding 3. Serious Adverse Event 4. International Index Of Erectile Function 5. Quality of Life 6. Erectile function 7. Sexual function 8. Patient-Reported Outcome
outcomes:
Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction
1. Adverse Drug Reaction 2. Live Birth 3. Complication 4. Ectopic Pregnancy 5. Miscarriage 6. Clinical Pregnancy
outcomes:
Vasodilators for women undergoing fertility treatment
1. Endometrial Thickness 2. Adverse Drug Reaction 3. Live Birth 4. Multiple Pregnancy 5. Ectopic Pregnancy 6. Clinical Pregnancy 7. Miscarriage
outcomes:
Pain relief for women undergoing oocyte retrieval for assisted reproduction
1. Postoperative Complication 2. Postoperative Pain 3. Livebirth 4. Clinical Pregnancy 5. Postoperative Nausea And Vomiting 6. Intraoperative Pain 7. Patient Satisfaction
outcomes:
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
1. Infection 2. Ongoing Pregnancy 3. Live Birth 4. Multiple Pregnancy 5. Ectopic Pregnancy 6. Miscarriage 7. Clinical Pregnancy
outcomes:
Anti‐adhesion therapy following operative hysteroscopy for treatment of female subfertility
1. Adhesions Of Uterus 2. Live Birth 3. Clinical Pregnancy 4. Miscarriage
outcomes:
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation
1. Number of Oocytes Aspirated 2. IVF cycle failure 3. Live Birth 4. Clinical Pregnancy 5. Dosage 6. Ovarian Hyperstimulation Syndrome
outcomes:
Pain relief for outpatient hysteroscopy
1. Pain 2. Allergic Reaction 3. Nausea And Vomiting 4. Vasovagal Attack
outcomes:
Cycle regimens for frozen‐thawed embryo transfer
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Miscarriage
outcomes:
Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
1. Poor response to ovulation induction 2. Ongoing Pregnancy 3. Live Birth 4. Miscarriage 5. Ovarian Hyperstimulation Syndrome
outcomes:
Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome
1. Multiple Pregnancy 2. Live Birth 3. Clinical Pregnancy 4. Miscarriage 5. Ovarian Hyperstimulation Syndrome
outcomes:
Septum resection for women of reproductive age with a septate uterus
1. Surgical complication 2. Ongoing Pregnancy 3. Live Birth 4. Complication Of Pregnancy 5. Clinical Pregnancy
outcomes:
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Clinical Pregnancy 5. Miscarriage 6. Ovarian Hyperstimulation Syndrome
outcomes:
Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Ectopic Pregnancy 5. Clinical Pregnancy 6. Miscarriage
outcomes:
Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation
1. Live Birth 2. Clinical Pregnancy 3. Miscarriage
outcomes:
Aspirin for in vitro fertilisation
1. Ongoing Pregnancy 2. Multiple Pregnancy 3. Vaginal Bleeding 4. Live Birth 5. Ectopic Pregnancy 6. Miscarriage 7. Clinical Pregnancy
outcomes:
Volume expanders for the prevention of ovarian hyperstimulation syndrome
1. Live Birth 2. Pregnancy 3. Adverse Event 4. Ovarian Hyperstimulation Syndrome
outcomes:
Progestin‐only contraceptives: effects on weight
1. Body Mass Index 2. Body Composition 3. Weight change
outcomes:
Hormonal contraceptives for contraception in overweight or obese women
1. Adverse Drug Reaction 2. Pregnancy
outcomes:
Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology
1. IVF cycle failure 2. Ongoing Pregnancy 3. Live Birth 4. Clinical Pregnancy 5. Miscarriage 6. Ovarian Hyperstimulation Syndrome
outcomes:
Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles
1. Ongoing Pregnancy 2. Live Birth 3. Clinical Pregnancy 4. Miscarriage 5. Adverse Event 6. Ovarian Hyperstimulation Syndrome
outcomes:
Psychological and educational interventions for subfertile men and women
1. Live Birth 2. Depression 3. Anxiety
outcomes:
Brief educational strategies for improving contraception use in young people
1. Attitude 2. Pregnancy 3. Contraception
outcomes:
Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women
1. Ongoing Pregnancy 2. Live Birth 3. Multiple Pregnancy 4. Ectopic Pregnancy 5. Miscarriage 6. Clinical Pregnancy
outcomes:
Assisted reproductive technologies for male subfertility
1. IVF cycle failure 2. Multiple Pregnancy 3. Live Birth 4. Miscarriage 5. Clinical Pregnancy 6. Ovarian Hyperstimulation Syndrome
outcomes:
Culture media for human pre‐implantation embryos in assisted reproductive technology cycles
1. Ongoing Pregnancy 2. Live Birth
outcomes:
Gonadotrophin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction
1. Live Birth 2. Clinical Pregnancy
outcomes:
Lactational amenorrhoea method for family planning
1. Normal Periods 2. Pregnancy
outcomes:
Pain relief in hysterosalpingography
1. Pain
outcomes:
Luteal phase support for assisted reproduction cycles
1. Live Birth 2. Clinical Pregnancy 3. Adverse Event
outcomes:
Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility
1. Number of Oocytes Aspirated 2. IVF cycle failure 3. Live Birth 4. Clinical Pregnancy 5. Adverse Event 6. Number of ovarian follicles
outcomes:
Gonadotropin‐releasing hormone agonist versus HCG for oocyte triggering in antagonist‐assisted reproductive technology
1. Ongoing Pregnancy 2. Live Birth 3. Miscarriage 4. Ovarian Hyperstimulation Syndrome
outcomes:
Vitrification versus slow freezing for women undergoing oocyte cryopreservation
1. Ongoing Pregnancy 2. Live Birth 3. Clinical Pregnancy 4. Adverse Event
outcomes:
Surgical intervention versus expectant management for endometrial polyps in subfertile women
1. Live Birth 2. Preterm Spontaneous Labor With Preterm Delivery 3. Complication 4. Clinical Pregnancy 5. Miscarriage
outcomes:
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
1. HbA1c level 2. C-peptide Level 3. Blood insulin level 4. Glucose
outcomes:
Oral contraceptives for functional ovarian cysts
1. Cyst Removal
outcomes:
Combination contraceptives: effects on weight
1. Weight change
outcomes:
Heparin for assisted reproduction
1. Live Birth 2. Clinical Pregnancy 3. Adverse Event
outcomes:
Exercise as adjunctive therapy for systemic lupus erythematosus
1. Serious Adverse Event 2. Functional Assessment of Chronic Illness Therapy-Fatigue 3. Short Form Health Survey - 36 4. Visual Analog Scale 5. Withdrawal Due To Adverse Events 6. Functional ability 7. Mental Health Component Summary 8. Fatigue Severity Scale 9. Systemic Lupus Erythematosus Disease Activity Index
outcomes:
Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee
1. Pain 2. Quality of Life 3. Withdrawal Due To Adverse Events 4. Joint 5. Functional ability 6. Patient's Global Evaluation
outcomes:
Stem cell transplantation for systemic sclerosis
1. Interstitial Lung Disease 2. Serious Adverse Event 3. Death 4. Pulmonary Hypertension 5. Skin thickness 6. Functional ability 7. Health Assessment Questionnaire
outcomes:
Dietary supplements for chronic gout
1. Disability 2. Serious Adverse Event 3. Gout 4. Tophus 5. Joint Pain 6. Uric Acid 7. Withdrawal Due To Adverse Events 8. Functional ability 9. Adverse Event 10. Subjective Global Assessment
outcomes:
Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain
1. Withdrawn From Research Study 2. Pain 3. Treatment Success 4. Visual Analog Scale 5. Adverse Event 6. Functional ability 7. Health-Related Quality of Life 8. Pain Relief
outcomes:
Colchicine for acute gout
1. Pain 2. Joint Movement 3. Adverse Event 4. Health-Related Quality of Life
outcomes:
Tramadol for osteoarthritis
1. Disability 2. Visual Analog Pain Scale 3. Serious Adverse Event 4. Pain 5. Withdrawal Due To Adverse Events 6. Functional ability 7. Adverse Event
outcomes:
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
1. Serious Adverse Event 2. Disease Activity Score In Rheumatoid Arthritis 3. Rheumatoid Arthritis 4. Disease Progression 5. Treatment Success 6. Decreased Therapeutic Response 7. Drug Therapy 8. Withdrawal Due To Adverse Events 9. Functional ability
outcomes:
Methotrexate for psoriatic arthritis
1. Serious Adverse Event 2. Withdrawal Due To Adverse Events 3. Psoriatic Arthritis 4. Functional ability 5. Diagnostic radiography 6. Health-Related Quality of Life 7. Therapeutic Response 8. Clinical Improvement
outcomes:
Exercise for rheumatoid arthritis of the hand
1. Pain 2. Finding Of Function Of Hand 3. Disease Activity Score In Rheumatoid Arthritis 4. Visual Analog Scale 5. Impairment Of Hand Function 6. Adverse Event
outcomes:
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review
1. Pain 2. Social Behavior 3. Quality of Life 4. Depression 5. Anxiety 6. Finding Of Self Perception, Self Concept Pattern 7. Functional ability 8. Adverse Event
outcomes:
Surgery for trigger finger
1. Pain 2. Finding Of Function Of Hand 3. Disease Recurrence 4. Treatment Success 5. Clinical Resolution 6. Neurovascular Injury 7. Adverse Event 8. Stenosing Tenosynovitis 9. Patient's Global Evaluation 10. Patient Satisfaction
outcomes:
Back Schools for chronic non‐specific low back pain
1. Disability 2. Pain 3. Return to Work 4. Adverse Event
outcomes:
Celecoxib for rheumatoid arthritis
1. Disability 2. Stroke 3. Myocardial Infarction 4. Joint Tenderness 5. Pain 6. Rheumatoid Arthritis 7. Cardiovascular Injury 8. Acute Phase Reaction 9. Peptic Ulcer 10. Adverse Event 11. Drug toxicity 12. Swollen Joints
outcomes:
Celecoxib for osteoarthritis
1. Disability 2. Cardiovascular finding 3. Serious Adverse Event 4. Pain 5. Quality of Life 6. Gastrointestinal Tract Finding 7. Withdrawal Due To Adverse Events 8. Functional ability
outcomes:
Exercise for hand osteoarthritis
1. Disability 2. Finding Of Function Of Hand 3. Hand Joint Stiff 4. Quality of Life 5. Hand Pain 6. Joint Finding 7. Withdrawal Due To Adverse Events 8. Adverse Event
outcomes:
Stretch for the treatment and prevention of contractures
1. Range of joint movement 2. Pain 3. Quality of Life 4. Adverse Event 5. Functional ability 6. Able To Perform All Activities Of Daily Living
outcomes:
Surgical options for lumbar spinal stenosis
1. Disability 2. Pain 3. Pain Scale 4. Repeat surgery 5. Surgery 6. Duration Of Surgery 7. Quality of Life 8. Haemorrhage 9. Complete response 10. Functional ability 11. Clinical Improvement 12. Pain Intensity
outcomes:
Bioabsorbable versus metallic interference screws for graft fixation in anterior cruciate ligament reconstruction
1. Migration Of Implant 2. Cyclops 3. Changes In Physical Activity 4. Superficial Injury With Infection 5. Treatment Failure 6. Graft Failure 7. Postoperative Wound Infection-deep 8. Implant Breakage 9. Range of motion of knee 10. Foreign Body Reaction 11. Arthrofibrosis
outcomes:
Electrotherapy modalities for rotator cuff disease
1. Disability 2. Pain 3. Shoulder Joint Painful On Movement 4. Treatment Success 5. Quality of Life 6. Global Assessment 7. Functional ability 8. Adverse Event
outcomes:
Biologic interventions for fatigue in rheumatoid arthritis
1. Fatigue 2. Adverse Event
outcomes:
Non‐steroidal anti‐inflammatory drugs for chronic low back pain
1. Disability 2. Pain 3. Pain Scale 4. Chronic Low Back Pain 5. Return to Work 6. Adverse Event 7. Functional ability 8. Pain Intensity 9. Clinical Improvement
outcomes:
Surgery for Dupuytren's contracture of the fingers
1. Finding Of Function Of Hand 2. Active Range Of Finger Flexion 3. Paresthesia 4. Dupuytren's Disease 5. Range Of Finger Extension 6. Adverse Event 7. Health-Related Quality of Life 8. Patient Satisfaction 9. Hypesthesia 10. Deformity Of Hand 11. Muscle Contracture 12. Disease Recurrence 13. Finding Of Hand Region
outcomes:
High‐intensity versus low‐intensity physical activity or exercise in people with hip or knee osteoarthritis
1. Disability 2. Serious Adverse Event 3. Pain 4. Quality of Life 5. Withdrawal Due To Adverse Events 6. Adverse Event 7. Functional ability
outcomes:
Radiofrequency denervation for chronic low back pain
1. Pain 2. Pain Scale 3. Complication 4. Functional ability 5. Health-Related Quality of Life 6. Clinical Improvement
outcomes:
Intra‐articular corticosteroid for knee osteoarthritis
1. Pain 2. Serious Adverse Event 3. Withdrawal Due To Adverse Events 4. Functional ability 5. Adverse Event
outcomes:
Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non‐radiographic axial spondyloarthritis)
1. Ankylosing Spondylitis 2. Pain 3. Serious Adverse Event 4. Mobility function 5. Non-radiographic Axial Spondylitis 6. Withdrawal Due To Adverse Events 7. Functional ability
outcomes:
TNF‐alpha inhibitors for ankylosing spondylitis
1. Ankylosing Spondylitis 2. Serious Adverse Event 3. Inflammation 4. Withdrawal Due To Adverse Events
outcomes:
Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and rheumatoid arthritis
1. Serious Adverse Event 2. Knee Pain 3. Death 4. Knee replacement 5. Functional ability 6. Knee osteoarthritis 7. Health-Related Quality of Life
outcomes:
Rituximab for rheumatoid arthritis
1. Serious Adverse Event 2. Rheumatoid Arthritis 3. Withdrawal Due To Adverse Events 4. Functional ability 5. Health-Related Quality of Life 6. Clinical Improvement
outcomes:
Exercise for osteoarthritis of the knee
1. Withdrawn From Research Study 2. Knee Pain 3. Quality of Life 4. Functional ability 5. Adverse Event
outcomes:
Sulfasalazine for ankylosing spondylitis
1. Bath Ankylosing Spondylitis Function Index 2. Serious Adverse Event 3. Pain 4. Bath Ankylosing Spondylitis Disease Activity Index 5. Adverse Event 6. Back pain
outcomes:
Uricosuric medications for chronic gout
1. Disability 2. Pain 3. Gout 4. Tophus 5. Uric Acid 6. Visual Analog Scale 7. Withdrawal Due To Adverse Events 8. Adverse Event 9. Functional ability 10. Pain Relief
outcomes:
Electrotherapy modalities for adhesive capsulitis (frozen shoulder)
1. Disability 2. Pain 3. Treatment Success 4. Quality of Life 5. Global Assessment 6. Adverse Event 7. Active Range Of Shoulder Abduction 8. Functional ability 9. Pain Relief 10. Patient-Reported Outcome
outcomes:
Interleukin‐1 inhibitors for acute gout
1. Disability 2. Pain 3. Serious Adverse Event 4. Treatment Success 5. Inflammation 6. Withdrawal Due To Adverse Events 7. Adverse Event 8. Functional ability 9. Health-Related Quality of Life 10. Pain Relief 11. Subjective Global Assessment
outcomes:
Manual therapy and exercise for adhesive capsulitis (frozen shoulder)
1. Disability 2. Pain 3. Treatment Success 4. Quality of Life 5. Global Assessment 6. Adverse Event 7. Active Range Of Shoulder Abduction 8. Functional ability 9. Pain Relief 10. Patient-Reported Outcome
outcomes:
Diacerein for osteoarthritis
1. Serious Adverse Event 2. Pain 3. Short Form Health Survey-12 Item 4. Radiographic progression 5. Quality of Life 6. Diarrhoea 7. General Physical Finding 8. Adverse Event 9. Lequesne Index
outcomes:
Self‐management education programmes for osteoarthritis
1. Activities of Daily Living 2. Withdrawn From Research Study 3. Patient engagement 4. Western Ontario And Mcmaster Universities Osteoarthritis Index 5. Self-management 6. Quality of Life 7. Clinical Global Impression 8. Osteoarthritis 9. Functional ability 10. Patient-Reported Outcome
outcomes:
Rehabilitation following surgery for lumbar spinal stenosis
1. Disability 2. Visual Analog Pain Scale 3. Oswestry Disability Index 4. Leg Pain 5. Low back pain 6. Visual Analog Scale 7. General Body State Finding 8. Roland-Morris Disability Questionnaire 9. Adverse Event
outcomes:
Lifestyle interventions for acute gout
1. Joint Function Disorder 2. Pain 3. Serious Adverse Event 4. Visual Analog Scale 5. Inflammation 6. Withdrawal Due To Adverse Events 7. Health-Related Quality of Life 8. Pain Relief 9. Patient's Global Evaluation
outcomes:
Non‐pharmacological interventions for fatigue in rheumatoid arthritis
1. Fatigue 2. Adverse Event 3. Patient-Reported Outcome
outcomes:
Erythropoiesis‐stimulating agents for anemia in rheumatoid arthritis
1. Withdrawn From Research Study 2. Adverse Drug Reaction 3. Poisoning By Antianemic Agent 4. Fatigue 5. Withdrawal Due To Adverse Events 6. Adverse Event 7. Health-Related Quality of Life 8. Hemoglobin concentration
outcomes:
Treatments for alopecia areata: a network meta‐analysis
1. Hair growth 2. Health-Related Quality of Life
outcomes:
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis
1. Serious Adverse Event 2. Psoriasis
outcomes:
Negative pressure wound therapy for treating pressure ulcers
1. Serious Adverse Event 2. Pressure ulcer 3. Wound Healing 4. Adverse Event
outcomes:
Silicone gel sheeting for treating keloid scars
1. Keloid Scar 2. Adverse Event
outcomes:
Dressings and topical agents for the management of open wounds after surgical treatment for sacrococcygeal pilonidal sinus
1. Costs and Cost Analysis 2. Pain 3. Wound healed 4. Time to complete wound healing 5. Adverse Event
outcomes:
Pressure redistributing static chairs for preventing pressure ulcers
1. Pressure ulcer 2. Patient comfort 3. Health-Related Quality of Life
outcomes:
Silicone gel sheeting for treating hypertrophic scars
1. Hypertrophic Scar 2. Adverse Event
outcomes:
Botulinum toxin type A for facial wrinkles
1. Clinician-Reported Outcome 2. Patient-Reported Outcome
outcomes:
Topical benzoyl peroxide for acne
1. Likert Scale
outcomes:
Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings
1. Skin fissures 2. Tear Of Skin 3. Skin Ulcer 4. Impaired Skin Integrity 5. Adverse Event
outcomes:
Interventions for chronic palmoplantar pustulosis
1. Partial clearance of lesions 2. Complete clearance of lesions 3. Adverse Event
outcomes:
Topical and device‐based treatments for fungal infections of the toenails
1. Disease Condition Determination, Cured 2. Adverse Event
outcomes:
Lifestyle changes for treating psoriasis
1. Clinical Improvement
outcomes:
Interventions for hand eczema
1. Therapeutic Response
outcomes:
Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
1. Relapse 2. Clinical Resolution 3. Physician's Global Evaluation 4. Psoriasis Area and Severity Index
outcomes:
Antistreptococcal interventions for guttate and chronic plaque psoriasis
1. Clinical Resolution 2. Physician's Global Evaluation 3. Psoriasis Area and Severity Index
outcomes:
Risk assessment tools for the prevention of pressure ulcers
1. Pressure ulcer
outcomes:
Support surfaces for treating pressure ulcers
1. Pressure ulcer 2. Wound Healing 3. Clinical Improvement
outcomes:
Education of healthcare professionals for preventing pressure ulcers
1. Patient knowledge 2. Pressure ulcer
outcomes:
Foam dressings for treating pressure ulcers
1. Quality of Life 2. Wound Healing 3. Adverse Event
outcomes:
Systemic antibiotics for treating malignant wounds
1. Wound Odor 2. Adverse Event
outcomes:
Anabolic steroids for treating pressure ulcers
1. Wound Healing 2. Adverse Event
outcomes:
Scalpel versus electrosurgery for major abdominal incisions
1. Postoperative Pain 2. Incised Wound 3. Wound Healing 4. Haemorrhage 5. Adhesion 6. Time-to-Event 7. Wound Dehiscence 8. Wound Infection
outcomes:
Drugs for discoid lupus erythematosus
1. Skin Appearance Normal 2. Quality of Life
outcomes:
Emollients and moisturisers for eczema
1. Likert Scale 2. Adverse Event
outcomes:
Wound drainage for lower limb arterial surgery
1. Surgical Site Infection 2. Wound Complication 3. Surgery 4. Health-Related Quality of Life 5. Wound Dehiscence
outcomes:
Bed rest for pressure ulcer healing in wheelchair users
1. Lower Respiratory Tract Infection 2. Decreased Muscle Function 3. Pressure ulcer 4. Wound Healing
outcomes:
Antibiotics and antiseptics for pressure ulcers
1. Wound Healing 2. Adverse Event
outcomes:
Interventions for acne scars
1. Scar Conditions And Fibrosis Of Skin 2. Adverse Event
outcomes:
Antibiotics and antiseptics for surgical wounds healing by secondary intention
1. Wound Healing 2. Adverse Event 3. Wound Infection
outcomes:
Surgical hand antisepsis to reduce surgical site infection
1. Surgical Site Infection 2. Postoperative Infection
outcomes:
Anti‐TNF agents for paediatric psoriasis
1. Paediatric Quality of Life Inventory 2. Quality of Life 3. Adverse Event 4. Psoriasis Area and Severity Index 5. Clinical Improvement
outcomes:
Interventions for hidradenitis suppurativa
1. Infection 2. Hidradenitis Suppurativa 3. Pain 4. Serious Adverse Event 5. Abscesses Score 6. Dermatology Life Quality Index 7. Quality of Life 8. Visual Analog Scale 9. Treatment discontinued 10. Sartorius Scale 11. Nodules Score 12. Adverse Event
outcomes:
Wound‐care teams for preventing and treating pressure ulcers
1. Pressure ulcer 2. Wound Healing
outcomes:
Oral fumaric acid esters for psoriasis
1. Adverse Event 2. Psoriasis Area and Severity Index 3. Clinical Improvement
outcomes:
Negative pressure wound therapy for treating surgical wounds healing by secondary intention
1. Wound Healing
outcomes:
Interventions for rosacea
1. Quality of Life 2. Adverse Event
outcomes:
Preoperative skin antiseptics for preventing surgical wound infections after clean surgery
1. Surgical Site Infection
outcomes:
Interventions for vitiligo
1. Skin Normal Color 2. Quality of Life 3. Adverse Event
outcomes:
Repositioning for treating pressure ulcers
1. Pressure ulcer 2. Wound Healing
outcomes:
Negative pressure wound therapy for partial‐thickness burns
1. Wound healed 2. Time to complete wound healing
outcomes:
Recombinant human growth hormone for treating burns and donor sites
1. Hyperglycemia 2. Septicemia 3. Death 4. Duration Of Hospital Stay 5. Wound Healing 6. Wound Infection
outcomes:
Removal of nail polish and finger rings to prevent surgical infection
1. Surgical Wound Infection
outcomes:
Topical agents and dressings for fungating wounds
1. Quality of Life
outcomes:
Pressure‐relieving devices for treating heel pressure ulcers
1. Ulcer Of Heel
outcomes:
Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for psoriasis
1. Psoriasis 2. Global Assessment 3. Adverse Event 4. Psoriasis Area and Severity Index
outcomes:
Antibiotic prophylaxis for preventing burn wound infection
1. Burn 2. Infection 3. Death 4. Adverse Event 5. Wound Infection
outcomes:
Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low‐ and middle‐income countries
1. Alcohol Use
outcomes:
Baclofen for alcohol use disorder
1. Relapse 2. Alcohol Use
outcomes:
Opioid agonist treatment for people who are dependent on pharmaceutical opioids
1. Opioid Abuse 2. Adverse Event
outcomes:
Music therapy for people with substance use disorders
1. Drug Craving 2. Brief Substance Craving Scale 3. University of Rhode Island Change Assessment Scale 4. Readiness to Change Questionnaire 5. Stages of Change Readiness and Treatment Eagerness Scale 6. State-Trait Anxiety Scale 7. Personal Motivation 8. Commitment to Sobriety Scale 9. Motivation 10. Hamilton Rating Scale For Depression 11. Alcohol Craving 12. Psychological Symptom 13. Beck Depression Inventory
outcomes:
Strategies to improve smoking cessation rates in primary care
1. Smoking cessation
outcomes:
Interventions to reduce tobacco use in people experiencing homelessness
1. Short-term abstinence 2. Long-term abstinence 3. Tobacco abstinence 4. Medium-term abstinence
outcomes:
Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders
1. Abstinent From Drug Misuse 2. Death
outcomes:
Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
1. Smoking cessation 2. Serious Adverse Event 3. Disease Activity Score 4. Disease Activity Score In Rheumatoid Arthritis Using C-reactive Protein 5. Adverse Event 6. Patient-Reported Outcome
outcomes:
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
1. Smoking cessation 2. Tobacco abstinence